Niagen Bioscience, Inc., formerly Chromadex Corp., is a global bioscience company. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. The Company’s Consumer Products segment provides finished dietary supplement products that contain the Company's proprietary ingredients directly to consumers and distributors and offers NAD+ test kits exclusively to healthcare practitioners. The Ingredients segment develops and commercializes proprietary-based ingredient technologies, including food-grade Niagen and pharmaceutical-grade Niagen, and supplies these ingredients as raw materials to the manufacturers of consumer products and United States FDA-registered 503B outsourcing facilities, respectively. The Analytical Reference Standards and Services segment offers the supply of phytochemical reference standards and other research and development services.
公司代码NAGE
公司名称Niagen Bioscience Inc
上市日期Jun 25, 2007
CEOFried (Robert N)
员工数量104
证券类型Ordinary Share
年结日Jun 25
公司地址10900 Wilshire Blvd Suite 600
城市LOS ANGELES
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编90024
电话13103886706
网址https://www.niagenbioscience.com/
公司代码NAGE
上市日期Jun 25, 2007
CEOFried (Robert N)